RFP | July 5, 2012
U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) announces the availability of funding for implementation of the NIAMS Clinical Trial Outcomes Instrument Development Grant Program (U01). The purpose of this grant is to develop and evaluate new and existing clinical trial outcomes measures to better assess the benefits (efficacy and effectiveness) and adverse impacts of therapies employed to treat diseases and injuries of interest to the NIAMS. Contractors should refer to Section VII, Agency Contacts in the RFP, for information regarding each Institute's grants management . . .